Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Changes

29 Jan 2025 07:00

RNS Number : 9976U
Chesnara PLC
29 January 2025
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

29th January 2025

 

CHESNARA plc

("Chesnara", "the Company" or the "Group")

 

BOARD CHANGES

 

Chesnara (CSN.L), the European life insurance consolidator, today announces the appointment of Gail Tucker as Non-Executive Director with immediate effect. Gail has also been appointed as a member of Audit & Risk Committee and Nomination & Governance Committee and will be proposed for election at the Company's AGM, expected to be on 13th May 2025. Gail also joins the Board of Chesnara's UK subsidiary, Countrywide Assured plc as a Non-Executive Director and it is intended will chair its Audit & Risk Committee subject to regulatory approval.

 

Jane Dale, Non-Executive Director, will stand down at the AGM having completed her 9-year term. At the same time, Gail Tucker will be appointed chair of the Audit & Risk Committee.

 

Gail is a recently retired 'Big Four' partner with over 30 years' experience in financial services audit, predominantly focused on the insurance sector. She has a high level of technical competence in international accounting and financial reporting, allied to which she brings a well-developed perspective on the UK life and pensions industry. A qualified accountant, Gail holds a BSc from the University of Warwick and a BA from The Open University. She sits on the boards of Breast Cancer Now and Institute of Chartered Accountants in England & Wales (ICAEW) Financial Services Board.

 

Chair Luke Savage commented:

 

'I am delighted to welcome Gail to the Board of Chesnara and she brings with her a wealth of reporting expertise including from her time as IFRS17 Global Technical Lead for PwC. She has advised insurance audit teams around the world and has sat on a number of technical committees. We are delighted to have attracted such talent into the group and I look forward to working with Gail as we prosecute our strategy and deliver further value to our policyholders and shareholders.'

 

There is no further information relating to Gail which would require disclosure under UKLR 6.4.8R.

 

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 20 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVORVOUAUAR
Date   Source Headline
29th Apr 20217:00 amRNSDirector/PDMR Shareholding
23rd Apr 20217:00 amRNSBlock listing Interim Review
19th Apr 20217:00 amRNSNotice of AGM
15th Apr 20217:00 amRNSAcquisition
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
30th Mar 20217:30 amRNSHolding(s) in Company
30th Mar 20217:00 amRNSFinal Results
15th Mar 20217:00 amRNSNotice of Results
5th Feb 20217:00 amRNSHolding(s) in Company
29th Jan 20217:00 amRNSTotal Voting Rights
1st Dec 20203:47 pmRNSHolding(s) in Company
23rd Oct 20207:00 amRNSBlock listing Interim Review
29th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSHalf-year Report
14th Sep 202012:07 pmRNSSecond Price Monitoring Extn
14th Sep 202012:02 pmRNSPrice Monitoring Extension
2nd Sep 20204:35 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSAcquisition
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:36 pmRNSPrice Monitoring Extension
1st Jul 202012:07 pmRNSSecond Price Monitoring Extn
1st Jul 202012:02 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSDirectorate Change
19th Jun 20207:00 amRNSNotice of Results
16th Jun 202011:31 amRNSDirector/PDMR Shareholding
8th Jun 202012:07 pmRNSSecond Price Monitoring Extn
8th Jun 202012:03 pmRNSPrice Monitoring Extension
29th May 20207:00 amRNSTotal Voting Rights
27th May 202012:07 pmRNSSecond Price Monitoring Extn
27th May 202012:02 pmRNSPrice Monitoring Extension
26th May 202012:28 pmRNSResult of AGM
20th May 202012:02 pmRNSPrice Monitoring Extension
5th May 20207:00 amRNSDoc re. Rights Attached to Equity Shares
1st May 20207:00 amRNSHolding(s) in Company
1st May 20207:00 amRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSBlock listing Interim Review
23rd Apr 20207:00 amRNSNotice of AGM
15th Apr 20204:00 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSFinal Results
6th Apr 20203:54 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSTrading Statement
23rd Mar 20207:15 amRNSNotice of Results
20th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20207:00 amRNSNotice of Results
14th Feb 20207:00 amRNSDirectorate Change
17th Dec 20197:00 amRNSChange of Adviser
22nd Nov 20197:00 amRNSAcquisition
25th Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20195:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.